scout
|Videos|April 26, 2017

An Overview of a Trial Exploring MEK162 in Advanced Biliary Cancer

Ghassan K. Abou-Alfa, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the trial of MEK162 in combination with gemcitabine and cisplatin in patients with untreated advanced biliary cancer.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME